Epoetin theta
Biopoin, Eporatio (epoetin theta) is a protein pharmaceutical. Epoetin theta was first approved as Biopoin on 2009-10-23. It has been approved in Europe to treat anemia, chronic kidney failure, and neoplasms.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Therapeutic Areas
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
640 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Anemia | D000740 | EFO_0004272 | D64.9 | 8 | 87 | 141 | 66 | 60 | 357 |
| Kidney diseases | D007674 | EFO_0003086 | N08 | 3 | 23 | 47 | 16 | 27 | 116 |
| Chronic renal insufficiency | D051436 | — | N18 | 5 | 20 | 50 | 16 | 23 | 114 |
| Renal insufficiency | D051437 | — | N19 | 4 | 12 | 22 | 12 | 8 | 57 |
| Chronic kidney failure | D007676 | EFO_0003884 | N18.6 | 3 | 11 | 20 | 9 | 9 | 52 |
| Neoplasms | D009369 | — | C80 | — | 14 | 15 | 5 | 10 | 44 |
| Syndrome | D013577 | — | — | 2 | 21 | 8 | 3 | 5 | 36 |
| Myelodysplastic syndromes | D009190 | — | D46 | 3 | 20 | 9 | 2 | 5 | 35 |
| Preleukemia | D011289 | — | — | 2 | 19 | 9 | 2 | 5 | 34 |
| Hiv infections | D015658 | EFO_0000764 | B20 | 1 | 6 | — | 4 | 8 | 19 |
Show 66 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Leukemia | D007938 | — | C95 | — | 7 | 7 | — | 1 | 15 |
| Wounds and injuries | D014947 | — | T14.8 | 1 | 6 | 4 | — | 5 | 14 |
| Multiple myeloma | D009101 | — | C90.0 | — | 2 | 7 | — | 4 | 13 |
| Brain injuries | D001930 | — | S06.9 | — | 6 | 5 | — | 1 | 10 |
| Plasma cell neoplasms | D054219 | — | — | — | 2 | 6 | — | 2 | 10 |
| Brain diseases | D001927 | — | G93.40 | 5 | 3 | 5 | — | — | 10 |
| Blood transfusion | D001803 | — | — | — | 4 | 5 | — | 4 | 10 |
| Plasmacytoma | D010954 | — | C90.3 | — | 2 | 5 | — | 1 | 8 |
| Brain ischemia | D002545 | EFO_0003883 | I67.82 | 5 | 3 | 3 | — | — | 8 |
| Brain hypoxia-ischemia | D020925 | EFO_1000846 | P91.6 | 5 | 3 | 3 | — | — | 8 |
Show 95 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 12 | 3 | — | — | 2 | 15 |
| Acquired immunodeficiency syndrome | D000163 | EFO_0000765 | B20 | 1 | 5 | — | — | — | 6 |
| Immunologic deficiency syndromes | D007153 | — | D84.9 | 1 | 5 | — | — | — | 6 |
| Ischemic stroke | D000083242 | — | — | 1 | 5 | — | — | — | 5 |
| Cardiac surgical procedures | D006348 | — | — | 1 | 2 | — | — | 2 | 4 |
| Coronary artery disease | D003324 | — | I25.1 | — | 3 | — | — | — | 3 |
| Reperfusion injury | D015427 | — | — | — | 1 | — | — | 2 | 3 |
| Paralysis | D010243 | — | — | 1 | 1 | — | — | 1 | 3 |
| Replacement arthroplasty knee | D019645 | — | — | — | 1 | — | — | 2 | 3 |
| Chronic disease | D002908 | — | — | — | 2 | — | — | 1 | 3 |
Show 64 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Aids-related complex | D000386 | EFO_0007137 | B20 | 1 | — | — | — | 2 | 3 |
| Reticulocyte count | D017701 | — | — | 1 | — | — | — | — | 1 |
| Pulmonary hypertension | D006976 | EFO_0001361 | I27.20 | 1 | — | — | — | — | 1 |
| Liver diseases | D008107 | EFO_0001421 | K70-K77 | 1 | — | — | — | — | 1 |
| Autoimmune hepatitis | D019693 | — | K75.4 | 1 | — | — | — | — | 1 |
| Parkinson disease | D010300 | EFO_0002508 | G20 | 1 | — | — | — | — | 1 |
| Cerebral hemorrhage | D002543 | — | — | 1 | — | — | — | — | 1 |
| Liver transplantation | D016031 | EFO_0010682 | — | 1 | — | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Cytopenia | D000095542 | — | — | — | — | — | — | 9 | 9 |
| Pancytopenia | D010198 | — | D61.81 | — | — | — | — | 8 | 8 |
| Substance-related disorders | D019966 | EFO_0003890 | F13 | — | — | — | — | 2 | 2 |
| Continuous ambulatory peritoneal dialysis | D010531 | — | — | — | — | — | — | 1 | 1 |
| Developmental disabilities | D002658 | EFO_0003852 | F89 | — | — | — | — | 1 | 1 |
| Metabolic diseases | D008659 | EFO_0000589 | E88.9 | — | — | — | — | 1 | 1 |
| Iron metabolism disorders | D019189 | — | E83.1 | — | — | — | — | 1 | 1 |
| Body weight | D001835 | EFO_0004338 | — | — | — | — | — | 1 | 1 |
| Scoliosis | D012600 | EFO_0004273 | M41 | — | — | — | — | 1 | 1 |
| Cerebrovascular disorders | D002561 | EFO_0003763 | I60-I69 | — | — | — | — | 1 | 1 |
Show 29 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Epoetin theta |
| INN | epoetin alfa |
| Description | Epoetin theta, sold under the brand name Biopoin among others, is a copy of the human hormone erythropoietin.
|
| Classification | Protein |
| Drug class | erythropoietins |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | 762263-14-9 |
| RxCUI | — |
| ChEMBL ID | CHEMBL2108290 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | 64FS3BFH5W (ChemIDplus, GSRS) |
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 3,413 documents
View more details
Safety
Black-box Warning
Black-box warning for: Epogen, Retacrit
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
34,906 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use